Annual EBITDA
-$42.63 M
-$3.22 M-8.17%
December 31, 2023
Summary
- As of February 7, 2025, ELDN annual EBITDA is -$42.63 million, with the most recent change of -$3.22 million (-8.17%) on December 31, 2023.
- During the last 3 years, ELDN annual EBITDA has fallen by -$26.63 million (-166.41%).
- ELDN annual EBITDA is now -736.95% below its all-time high of -$5.09 million, reached on December 31, 2016.
Performance
ELDN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$20.43 M
-$6.03 M-41.83%
September 30, 2024
Summary
- As of February 7, 2025, ELDN quarterly EBITDA is -$20.43 million, with the most recent change of -$6.03 million (-41.83%) on September 30, 2024.
- Over the past year, ELDN quarterly EBITDA has dropped by -$9.33 million (-84.00%).
- ELDN quarterly EBITDA is now -2092.17% below its all-time high of -$932.00 thousand, reached on June 30, 2016.
Performance
ELDN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$55.85 M
-$9.33 M-20.05%
September 30, 2024
Summary
- As of February 7, 2025, ELDN TTM EBITDA is -$55.85 million, with the most recent change of -$9.33 million (-20.05%) on September 30, 2024.
- Over the past year, ELDN TTM EBITDA has dropped by -$13.53 million (-31.95%).
- ELDN TTM EBITDA is now -1561.83% below its all-time high of -$3.36 million, reached on September 30, 2013.
Performance
ELDN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ELDN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.2% | -84.0% | -31.9% |
| 3 y3 years | -166.4% | -84.0% | -31.9% |
| 5 y5 years | -203.4% | -84.0% | -31.9% |
ELDN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.2% | at low | -122.3% | at low | -52.3% | at low |
| 5 y | 5-year | -204.4% | at low | -894.2% | at low | -431.2% | at low |
| alltime | all time | -737.0% | +5.6% | -2092.2% | at low | -1561.8% | at low |
Eledon Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.43 M(+41.8%) | -$55.85 M(+20.0%) |
| Jun 2024 | - | -$14.40 M(+33.7%) | -$46.53 M(+9.8%) |
| Mar 2024 | - | -$10.77 M(+5.2%) | -$42.38 M(-0.6%) |
| Dec 2023 | -$42.63 M(+8.2%) | -$10.24 M(-7.7%) | -$42.63 M(+0.7%) |
| Sep 2023 | - | -$11.10 M(+8.2%) | -$42.33 M(+1.4%) |
| Jun 2023 | - | -$10.26 M(-6.9%) | -$41.73 M(+2.6%) |
| Mar 2023 | - | -$11.02 M(+10.8%) | -$40.66 M(+3.2%) |
| Dec 2022 | -$39.41 M(+7.5%) | -$9.95 M(-5.3%) | -$39.41 M(+1.6%) |
| Sep 2022 | - | -$10.51 M(+14.3%) | -$38.78 M(+0.1%) |
| Jun 2022 | - | -$9.19 M(-5.9%) | -$38.74 M(+3.4%) |
| Mar 2022 | - | -$9.77 M(+4.7%) | -$37.48 M(+2.2%) |
| Dec 2021 | -$36.67 M(+129.2%) | -$9.32 M(-10.9%) | -$36.67 M(+8.9%) |
| Sep 2021 | - | -$10.46 M(+32.0%) | -$33.66 M(+22.4%) |
| Jun 2021 | - | -$7.93 M(-11.5%) | -$27.50 M(+27.2%) |
| Mar 2021 | - | -$8.96 M(+41.9%) | -$21.63 M(+35.2%) |
| Dec 2020 | -$16.00 M(+14.3%) | -$6.31 M(+46.8%) | -$16.00 M(+34.0%) |
| Sep 2020 | - | -$4.30 M(+109.2%) | -$11.94 M(+13.6%) |
| Jun 2020 | - | -$2.06 M(-38.3%) | -$10.52 M(-15.9%) |
| Mar 2020 | - | -$3.33 M(+47.8%) | -$12.50 M(-10.7%) |
| Dec 2019 | -$14.00 M(-0.3%) | -$2.25 M(-21.6%) | -$14.00 M(-14.2%) |
| Sep 2019 | - | -$2.87 M(-28.9%) | -$16.32 M(-3.7%) |
| Jun 2019 | - | -$4.04 M(-16.3%) | -$16.94 M(+5.3%) |
| Mar 2019 | - | -$4.83 M(+5.6%) | -$16.09 M(+14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$14.05 M(+7.3%) | -$4.57 M(+30.8%) | -$14.05 M(+21.4%) |
| Sep 2018 | - | -$3.50 M(+9.7%) | -$11.58 M(+4.8%) |
| Jun 2018 | - | -$3.19 M(+14.1%) | -$11.04 M(-23.9%) |
| Mar 2018 | - | -$2.79 M(+32.9%) | -$14.51 M(+10.8%) |
| Dec 2017 | -$13.10 M(+157.2%) | -$2.10 M(-29.1%) | -$13.10 M(+5.2%) |
| Sep 2017 | - | -$2.96 M(-55.5%) | -$12.45 M(+12.1%) |
| Jun 2017 | - | -$6.65 M(+381.8%) | -$11.10 M(+106.4%) |
| Mar 2017 | - | -$1.38 M(-4.6%) | -$5.38 M(-65.1%) |
| Dec 2016 | -$5.09 M(-88.7%) | -$1.45 M(-10.5%) | -$15.42 M(-38.3%) |
| Sep 2016 | - | -$1.62 M(+73.5%) | -$24.99 M(-29.1%) |
| Jun 2016 | - | -$932.00 K(-91.8%) | -$35.25 M(-18.6%) |
| Mar 2016 | - | -$11.43 M(+3.7%) | -$43.28 M(-4.1%) |
| Dec 2015 | -$45.15 M(+92.6%) | -$11.02 M(-7.2%) | -$45.15 M(+11.8%) |
| Sep 2015 | - | -$11.88 M(+32.4%) | -$40.39 M(+15.6%) |
| Jun 2015 | - | -$8.97 M(-32.6%) | -$34.94 M(+9.7%) |
| Mar 2015 | - | -$13.29 M(+112.5%) | -$31.85 M(+35.9%) |
| Dec 2014 | -$23.44 M(+48.9%) | -$6.26 M(-2.5%) | -$23.44 M(+3.1%) |
| Sep 2014 | - | -$6.42 M(+9.2%) | -$22.73 M(+15.5%) |
| Jun 2014 | - | -$5.88 M(+20.3%) | -$19.67 M(+42.6%) |
| Mar 2014 | - | -$4.89 M(-11.9%) | -$13.79 M(+54.9%) |
| Dec 2013 | -$15.74 M(+63.3%) | -$5.55 M(+65.0%) | -$8.91 M(+165.0%) |
| Sep 2013 | - | -$3.36 M | -$3.36 M |
| Dec 2012 | -$9.64 M | - | - |
FAQ
- What is Eledon Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual EBITDA year-on-year change?
- What is Eledon Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Eledon Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals TTM EBITDA year-on-year change?
What is Eledon Pharmaceuticals annual EBITDA?
The current annual EBITDA of ELDN is -$42.63 M
What is the all time high annual EBITDA for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual EBITDA is -$5.09 M
What is Eledon Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ELDN annual EBITDA has changed by -$3.22 M (-8.17%)
What is Eledon Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ELDN is -$20.43 M
What is the all time high quarterly EBITDA for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly EBITDA is -$932.00 K
What is Eledon Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ELDN quarterly EBITDA has changed by -$9.33 M (-84.00%)
What is Eledon Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ELDN is -$55.85 M
What is the all time high TTM EBITDA for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high TTM EBITDA is -$3.36 M
What is Eledon Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ELDN TTM EBITDA has changed by -$13.53 M (-31.95%)